• 1
    Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002; 52: 2347.
  • 2
    Ries L, Eisner M, Kosary C, et al. SEER Cancer Statistics Review, 1973–1998. Bethesda, MD: National Cancer Institute, 2001.
  • 3
    Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer. 2000; 88: 23982424.
  • 4
    Baquet CR, Commiskey P. Colorectal cancer epidemiology in minorities: a review. J Assoc Acad Minor Phys. 1999; 10: 5158.
  • 5
    Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale [see comments] [published errata appear in Gastroenterology. 1997;112:1060 and 1998;114:625]. Gastroenterology. 1997; 112: 594642.
  • 6
    Tomeo CA, Colditz GA, Willett WC, et al. Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control. 1999; 10: 167180.
  • 7
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study [published erratum appears in N Engl J Med. 1993;329:672] [see comments]. N Engl J Med. 1993; 328: 13651371.
  • 8
    National Cancer Institute. Conquering colorectal cancer: a blueprint for the future--The report of the Colorectal Cancer Progress Review Group. Bethesda, MD: National Cancer Institute, 2000.
  • 9
    Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000; 284: 19541561.
  • 10
    Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000; 133: 573584.
  • 11
    Wagner JL, Tunis J, Brown M, Ching A, Almeida R. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: YoungG, LevinB, editors. Prevention and early detection of colorectal cancer. London: Saunders, 1996: 321356.
  • 12
    Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2002; 137: 96104.
  • 13
    Smith RA, von Eschenbach AC, Wender RD, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin. 2001; 51: 3875; quiz, 77–80.
  • 14
    Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive services task force. Ann Intern Med. 2002; 137: 132141.
  • 15
    Centers for Disease Control and Prevention. Trends in screening for colorectal cancer--United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep. 2001; 50: 162166.
  • 16
    Centers for Disease Control. Self-reported use of mammography and insurance status among women aged > or =40 years--United States, 1991-1992 and 1996-1997. MMWR Morb Mortal Wkly Rep 1998; 47: 839830.
  • 17
    Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med. 2000; 31: 410416.
  • 18
    Mandelson MT, Curry SJ, Anderson LA, et al. Colorectal cancer screening participation by older women. Am J Prev Med. 2000; 19: 149154.
  • 19
    Vernon SW. Participation in colorectal cancer screening: a review [see comments]. J Natl Cancer Inst. 1997; 89: 14061422.
  • 20
    Weitzman ER, Zapka J, Estabrook B, Goins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med. 2001; 32: 502513.
  • 21
    Rawl SM, Menon U, Champion VL, Foster JL, Skinner CS. Colorectal cancer screening beliefs. Focus groups with first-degree relatives. Cancer Pract. 2000; 8: 3237.
  • 22
    Peterson SK, Vernon SW. A review of patient and physician adherence to colorectal cancer screening guidelines. Semin Colon Rectal Surg. 2000; 11: 5872.
  • 23
    Batelle Corporation. Evaluation of physicians' knowledge, attitudes, and practices related to screening for colorectal cancer. Atlanta, GA: American Cancer Society, 1998.
  • 24
    Cooper GS, Fortinsky RH, Hapke R, Landefeld CS. Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer. 1998; 82: 14761481.
  • 25
    Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999; 14: 432437.
  • 26
    Sharma VK, Corder FA, Fancher J, Howden CW. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am J Gastroenterol. 2000; 95: 36293632.
    Direct Link:
  • 27
    Yamamoto M, Nakama H. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology. 2000; 47: 396399.
  • 28
    Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 1999; 91: 16411646.
  • 29
    Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001; 345: 555560.
  • 30
    Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group [see comments]. N Engl J Med. 2000; 342: 17661772.
  • 31
    Dominitz JA, Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol. 1997; 92: 21712178.
  • 32
    Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997; 45: 211218.
  • 33
    Gordon NP, Rundall TG, Parker L. Type of health care coverage and the likelihood of being screened for cancer. Med Care. 1998; 36: 636645.
  • 34
    Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs? Ann Intern Med. 1999; 130: 525530.
  • 35
    Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 1. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997; 277: 915919.
  • 36
    Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 1996; 78: 11491167.
  • 37
    Yarnall KS, Rimer BK, Hynes D, et al. Computerized prompts for cancer screening in a community health center. J Am Board Fam Pract. 1998; 11: 96104.
  • 38
    McPhee SJ, Detmer WM. Office-based interventions to improve delivery of cancer prevention services by primary care physicians. Cancer. 1993; 72 (3 Suppl ): 11001112.
  • 39
    Walsh JM, McPhee SJ. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q. 1992; 19: 157175.
  • 40
    McPhee SJ, Bird JA, Fordham D, Rodnick JE, Osborn EH. Promoting cancer prevention activities by primary care physicians. Results of a randomized, controlled trial. JAMA. 1991; 266: 538544.
  • 41
    Bird JA, McPhee SJ, Jenkins C, Fordham D. Three strategies to promote cancer screening. How feasible is wide-scale implementation? Med Care. 1990; 28: 10051012.
  • 42
    McPhee SJ, Bird JA, Jenkins CN, Fordham D. Promoting cancer screening. A randomized, controlled trial of three interventions. Arch Intern Med 1989; 149: 18661872.
  • 43
    Dietrich AJ, Sox CH, Tosteson TD, Woodruff CB. Durability of improved physician early detection of cancer after conclusion of intervention support. Cancer. Epidemiol Biomarkers Prev 1994; 3: 335340.
  • 44
    Bejes C, Marvel MK. Attempting the improbable: offering colorectal cancer screening to all appropriate patients. Fam Pract Res J. 1992; 12: 8390.
  • 45
    Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Community Health. 2000; 25: 263278.
  • 46
    Garr DR, Ornstein SM, Jenkins RG, Zemp LD. The effect of routine use of computer-generated preventive reminders in a clinical practice. Am J Prev Med. 1993; 9: 5561.
  • 47
    Hulscher ME, Wensing M, Grol RP, van der Weijden T, van Weel C. Interventions to improve the delivery of preventive services in primary care. Am J Public Health. 1999; 89 (5): 737746.
  • 48
    Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med. 2000; 31: 323334.
  • 49
    Jorgensen CM, Gelb CA, Merritt TL, Seeff LC. Observations from the CDC: CDC's Screen for Life: a National Colorectal Cancer Action Campaign. J Womens Health Gend Based Med. 2001; 10: 417422.
  • 50
    Centers for Disease Control and Prevention. Screen for life, 2002. Atlanta: Centers for Disease Control and Prevention, 2002. URL:
  • 51
    The Advertising Council. The Advertising Council and the American Cancer Society launch PSAs to promote ealry colon cancer detection: The Advertising Council, 2002. URL:
  • 52
    Nattinger AB, Hoffmann RG, Howell-Pelz A, Goodwin JS. Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. JAMA. 1998; 279: 762766.
  • 53
    Brown ML, Potosky AL. The presidential effect: the public health response to media coverage about Ronald Reagan's colon cancer episode. Public Opin Q. 1990; 54: 317329.
  • 54
    Malin JL, Kahn K, Dulai G, et al. Organizational systems used by California capitated medical groups and independent practice associations to increase cancer screening. Cancer. 2000; 88: 28242831.
  • 55
    Fletcher RH, Colditz GA, Pawlson LG, Richman H, Rosenthal D, Salber PR. Screening for colorectal cancer: the business case. Am J Manag Care. 2002; 8: 531538.
  • 56
    Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology. 1995; 109: 178190.
  • 57
    Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380 [see comments]. N Engl J Med. 2000; 343: 162168.
  • 58
    Fronstin P. The working uninsured: who they are, how they have changed, and the consequences of being uninsured--with presidential candidate proposals outlined. EBRI Issue Brief. 2000: 123.
  • 59
    Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992; 268: 240248.
  • 60
    Greer AL. The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care. 1988; 4: 526.
  • 61
    Rogers EM. Diffusion of Innovations. Volume 155. New York: Free Press, 1995.
  • 62
    Rex DK. Colorectal cancer screening: a guide to the guidelines. Can J Gastroenterol. 1999; 13: 397402.
  • 63
    Schneider EC, Riehl V, Courte-Wienecke S, Eddy DM, Sennett C. Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Quality Assurance. JAMA. 1999; 282: 11841190.
  • 64
    Fletcher RH, Farraye FA. Screening flexible sigmoidoscopy: effectiveness is not enough. Gastroenterology. 1999; 117: 486488.
  • 65
    Schroy PC, Heeren T, Bliss CM, Pincus J, Wilson S, Prout M. Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology. 1999; 117: 304311.
  • 66
    Fleisher M, Winawer SJ, Zauber AG, Smith C, Schwartz MK. Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group. Ann Intern Med. 1991; 114: 875876.
  • 67
    Meyer GS, Jacoby I, Krakauer H, Powell DW, Aurand J, McCardle P. Gastroenterology workforce modeling. JAMA. 1996; 276: 689694.
  • 68
    Schoenfeld P, Lipscomb S, Crook J, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology. 1999; 117: 312318.
  • 69
    Physicians Insurers Association of America, PIAA Breast Cancer Study. Washington, DC: Physicians Insurers Association of America, 1995.
  • 70
    Selby JV, Friedman GD, Quesenberry CPJ, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer [see comments]. N Engl J Med. 1992; 326: 653657.
  • 71
    Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999; 281: 16111617.
  • 72
    Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, SW V. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. National Cancer Institute. Applied research program's role in physician surveys. Rockville, VA: National Cancer Institute, 2002. URL:
  • 73
    Bowdy M. Lag in colorectal screening rates prompts innovation. J Natl Cancer Inst. 1998; 90: 886887.
  • 74
    Fenlon HM, Nunes DP, Schroy PC 3rd, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999; 341: 14961503.
  • 75
    Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. 2000; 119: 12191227.
  • 76
    Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med. 2002; 346: 311320.
  • 77
    Fletcher RH. Should all people over the age of 50 have regular fecal occult-blood tests? If it works, why not do it? N Engl J Med. 1998; 338: 11531154; discussion 54–55.
  • 78
    Cokkinides V, Chao A, Smith RA, Vernon SW, Thun MJ. Correlates of under-utilization of colorectal cancer screening tests among U.S. adults age 50 years and older. Prev Med. In press.